A detailed history of Johnson Financial Group, Inc. transactions in Sanofi stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 733 shares of SNY stock, worth $35,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
733
Previous 654 12.08%
Holding current value
$35,389
Previous $31,000 35.48%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$48.54 - $58.53 $3,834 - $4,623
79 Added 12.08%
733 $42,000
Q2 2024

Aug 14, 2024

BUY
$45.39 - $50.36 $5,174 - $5,741
114 Added 21.11%
654 $31,000
Q1 2024

May 14, 2024

SELL
$45.75 - $52.48 $3,797 - $4,355
-83 Reduced 13.32%
540 $26,000
Q4 2023

Feb 09, 2024

BUY
$43.13 - $54.79 $26,869 - $34,134
623 New
623 $30,000
Q2 2022

Aug 15, 2022

SELL
$48.99 - $57.46 $30,373 - $35,625
-620 Reduced 45.29%
749 $37,000
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $10,826 - $12,040
230 Added 20.19%
1,369 $69,000
Q1 2021

May 14, 2021

BUY
$45.46 - $50.51 $17,729 - $19,698
390 Added 52.07%
1,139 $56,000
Q2 2020

Aug 11, 2020

SELL
$42.91 - $52.5 $5,749 - $7,035
-134 Reduced 15.18%
749 $38,000
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $752 - $864
-17 Reduced 1.89%
883 $44,000
Q3 2019

Nov 12, 2019

BUY
$40.34 - $46.64 $685 - $792
17 Added 1.93%
900 $42,000
Q2 2019

Aug 09, 2019

SELL
$40.43 - $44.3 $889 - $974
-22 Reduced 2.43%
883 $38,000
Q1 2019

May 13, 2019

BUY
$40.83 - $45.43 $31,479 - $35,026
771 Added 575.37%
905 $40,000
Q4 2018

Feb 11, 2019

SELL
$41.48 - $45.59 $7,839 - $8,616
-189 Reduced 58.51%
134 $6,000
Q3 2018

Nov 09, 2018

BUY
$40.0 - $44.84 $7,560 - $8,474
189 Added 141.04%
323 $14,000
Q3 2017

Nov 09, 2017

BUY
$47.04 - $50.34 $6,303 - $6,745
134
134 $7,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.